Alex Ekwueme Federal University Teaching Hospital Report issue

Academic/Hospital Phase 1 Phase 2

Organization Overview

First Clinical Trial
2017
NCT04501289
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Adebayo Joshua Adeniyi | Alex Ekwueme Federal University Teaching Hospital | Alex Ekwueme Federal University Teaching Hospital, Abakaliki | ALEX EKWUEME FEDERAL UNIVERSITY TEACHING HOSPITAL, ABAKALIKI, EBONYI STATE, NIGERIA | Uwakwe Emmanuel Chijioke

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hemorrhage (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 6
  • # of Trial APIs: 8